Fassio, A.; Galvagni, I.; Sartoris, S.; Cassandrini, D.A.; Aldegheri, F.; Rossini, M.; Pollastri, F.; Adami, G.; Gatti, D.; Somma, R.;
et al. Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies. Diagnostics 2026, 16, 64.
https://doi.org/10.3390/diagnostics16010064
AMA Style
Fassio A, Galvagni I, Sartoris S, Cassandrini DA, Aldegheri F, Rossini M, Pollastri F, Adami G, Gatti D, Somma R,
et al. Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies. Diagnostics. 2026; 16(1):64.
https://doi.org/10.3390/diagnostics16010064
Chicago/Turabian Style
Fassio, Angelo, Isotta Galvagni, Silvia Sartoris, Denise Alessandra Cassandrini, Federico Aldegheri, Maurizio Rossini, Francesco Pollastri, Giovanni Adami, Davide Gatti, Rosanna Somma,
and et al. 2026. "Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies" Diagnostics 16, no. 1: 64.
https://doi.org/10.3390/diagnostics16010064
APA Style
Fassio, A., Galvagni, I., Sartoris, S., Cassandrini, D. A., Aldegheri, F., Rossini, M., Pollastri, F., Adami, G., Gatti, D., Somma, R., Appoloni, M., Carletto, A., Bronte, V., & Arcolaci, A.
(2026). Longitudinal Comparison of Calprotectin and C-Reactive Protein in Rheumatoid Arthritis: Real-World Evidence Across Three Targeted Therapies. Diagnostics, 16(1), 64.
https://doi.org/10.3390/diagnostics16010064
